Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis
- PMID: 20487553
- PMCID: PMC2896340
- DOI: 10.1186/1471-230X-10-49
Nutrigenomics therapy of hepatisis C virus induced-hepatosteatosis
Abstract
Nutrigenomics is a relatively new branch of nutrition science, which aim is to study the impact of the foods we eat on the function of our genes. Hepatosteatosis is strongly associated with hepatitis C virus infection, which is known to increase the risk of the disease progression and reduce the likelihood of responding to anti- virus treatment. It is well documented that hepatitis C virus can directly alter host cell lipid metabolism through nuclear transcription factors. To date, only a limited number of studies have been on the effect of human foods on the nuclear transcription factors of hepatitis C virus -induced hepatosteatosis.Three nutrients, selected among 46 different nutrients: beta-carotene, vitamin D2, and linoleic acid were found in a cell culture system to inhibit hepatitis C virus RNA replication. In addition, polyunsaturated fatty acids (PUFAs) especially arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) have been demonstrated to inhibit hepatitis C virus RNA replication. These PUFAs, in particular the highly unsaturated n-3 fatty acids change the gene expression of PPARa and SREBP, suppress the expression of mRNAs encoding key metabolic enzymes and hereby suppress hepatic lipogenesis and triglyceride synthesis, as well as secretion and accumulation in tissues. A recent prospective clinical trial of 1,084 chronic hepatitis C patients compared to 2,326 healthy subjects suggests that chronic hepatitis C patients may benefit from strict dietary instructions.Increasing evidence suggest that some crucial nuclear transcription factors related to hepatitis C virus -associated hepatosteatosis and hepatitis C virus RNA itself can be controlled by specific anti- hepatitis C virus nutrition. It seems important that these findings are taken into account and specific nutritional supplements developed to be used in combination with interferon as adjunctive therapy with the aim to improve both the early as well as the sustained virological response.
Similar articles
-
Nutrigenomics and nutrigenetics of ω3 polyunsaturated fatty acids.Prog Mol Biol Transl Sci. 2012;108:75-112. doi: 10.1016/B978-0-12-398397-8.00004-6. Prog Mol Biol Transl Sci. 2012. PMID: 22656374 Review.
-
Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections.J Virol. 2019 Aug 28;93(18):e00811-19. doi: 10.1128/JVI.00811-19. Print 2019 Sep 15. J Virol. 2019. PMID: 31243135 Free PMC article.
-
Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication.Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Sep;1863(9):1041-1056. doi: 10.1016/j.bbalip.2018.06.002. Epub 2018 Jun 6. Biochim Biophys Acta Mol Cell Biol Lipids. 2018. PMID: 29885363
-
Lipid droplets and hepatitis C virus infection.Biochim Biophys Acta. 2009 Jun;1791(6):552-9. doi: 10.1016/j.bbalip.2008.12.012. Epub 2009 Jan 3. Biochim Biophys Acta. 2009. PMID: 19167518 Review.
-
Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture.Antimicrob Agents Chemother. 2007 Jun;51(6):2016-27. doi: 10.1128/AAC.01426-06. Epub 2007 Apr 9. Antimicrob Agents Chemother. 2007. PMID: 17420205 Free PMC article.
Cited by
-
Antiviral activity of eicosapentaenoic acid against zika virus and other enveloped viruses.Front Pharmacol. 2025 Apr 4;16:1564504. doi: 10.3389/fphar.2025.1564504. eCollection 2025. Front Pharmacol. 2025. PMID: 40255573 Free PMC article.
-
Elevated ratio of arachidonic acid to long-chain omega-3 fatty acids predicts depression development following interferon-alpha treatment: relationship with interleukin-6.Brain Behav Immun. 2013 Jul;31:48-53. doi: 10.1016/j.bbi.2012.08.007. Epub 2012 Aug 19. Brain Behav Immun. 2013. PMID: 22926083 Free PMC article.
-
Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?Int J Mol Sci. 2024 May 11;25(10):5238. doi: 10.3390/ijms25105238. Int J Mol Sci. 2024. PMID: 38791276 Free PMC article. Review.
-
Beneficial role of bioactive lipids in the pathobiology, prevention, and management of HBV, HCV and alcoholic hepatitis, NAFLD, and liver cirrhosis: A review.J Adv Res. 2018 Dec 21;17:17-29. doi: 10.1016/j.jare.2018.12.006. eCollection 2019 May. J Adv Res. 2018. PMID: 31193303 Free PMC article. Review.
-
Carotenoids and non-alcoholic fatty liver disease.Hepatobiliary Surg Nutr. 2015 Jun;4(3):161-71. doi: 10.3978/j.issn.2304-3881.2015.01.11. Hepatobiliary Surg Nutr. 2015. PMID: 26151056 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials